TITLE

A glimmer of hope

PUB. DATE
July 1996
SOURCE
New Scientist;7/20/96, Vol. 151 Issue 2039, p3
SOURCE TYPE
Periodical
DOC. TYPE
Editorial
ABSTRACT
Editorial. Comments on the progress made by the 1996 international conference on AIDS in Vancouver, British Columbia. Studies reporting the near elimination of HIV from the blood treated with cocktails of drugs that block the replication of the virus; Addition of protease inhibitors to the drug AZT; Uncertainties on the efficacy of the drug cocktails.
ACCESSION #
9612111547

 

Related Articles

  • A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; Chave, Jean-Philippe; Yerly, Sabine; Bisset, Leslie R.; Fischer, Marek; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel; Ledergerber, Bruno; G√ľnthard, Huldrych; Howe, Colin; Weber, Rainer; Perrin, Luc // Journal of Infectious Diseases;5/1/2002, Vol. 185 Issue 9, p1251 

    This randomized study evaluated the efficacy and tolerability of continued treatment with protease inhibitor plus nucleoside-analogue combination regimens (n = 79) or a change to the simplified regimen of abacavir-lamivudine-zidovudine (n = 84) in patients with suppressed human immunodeficiency...

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

  • An antiviral breakthrough. Cohan, Gary R. // Advocate;2/7/95, Issue 674, p43 

    Reports on using AZT with a new drug called 3TC as HIV treatment. Problems with the medications; Benefits and effectiveness of the drug combination.

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...

  • Primary Lamivudine Resistance in Acute/Early Human Immunodeficiency Virus Infection. Conway, Brian; Montessori, Valentina; Rouleau, Danielle; Montaner, Julio S.G.; O'Shaughnessy, Michael V.; Fransen, Signe; Shillington, Andrew; Weislow, Owen; Mayers, Douglas L. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p910 

    Focuses on a study which described primary resistance to zidovudine in acute and early HIV infection. Patients and methods; Detection of drug resistance; Cases of transmission of resistant virus strains.

  • Early zidovudine treatment for patients with HIV infection.  // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2358 

    Reports on a study on the use of early zidovudine treatment in asymptomatic patients with HIV infections in the United States, as presented in the August 17, 1995 issue of `New England Journal of Medicine.' Comparison between immediate and deferred zidovudine treatment; Effectiveness of...

  • The duration of zidovudine benefit in persons with asymptomatic HIV infection. Volberding, Paul A.; Lagakos, Stephen W. // JAMA: Journal of the American Medical Association;8/10/94, Vol. 272 Issue 6, p437 

    Determines the durability of zidovudine-induced delay in clinical progression of asymptomatic human immunodeficiency virus disease. Entry characteristics, treatment and follow-up history; Overall progression to AIDS or death; Progression to AIDS or death for the zidovudine and censored placebo...

  • Beginning to Make Progress against HIV. Wilfert, Catherine M. // New England Journal of Medicine;11/28/96, Vol. 335 Issue 22, p1678 

    Opinion. Discusses efforts to reduce perinatal human immunodeficiency virus (HIV) infection. Evidence of the preventive efficacy of zidovudine demonstrated by Sperling et al.; How Sperling's work, called Protocol 076, is being implemented in the United States; Details of three studies...

  • Treatment New From Stockholm. Helquist, Michael // Advocate;8/16/88, Issue 505, p26 

    Presents insights from the Fourth International Conference on AIDS. Possibility of eradicating HIV infections; Use of AZT for treating AIDS; Result of combining with other drugs; Findings in Stockholm, Sweden regarding the prospects of the anti-AIDS drug called IMREG-1.

  • Zidovudine-induced macular edema. Lalonde, Richard G.; Deschenes, Jean G.; Seamone, Christopher; Lalonde, R G; Desch√™nes, J G; Seamone, C // Annals of Internal Medicine;2/15/91, Vol. 114 Issue 4, p297 

    Presents a study that reported the case of a patient with HIV infection and chronic anterior uveitis who had two episodes of serious visual impairment which occurred shortly after the institution of zidovudine therapy. Condition that is common during HIV infection; Reason for the possibility...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics